Longitudinal DLQI trajectory patterns and early risk updating in telepharmacy-monitored psoriasis.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Ward clustering of psoriasis quality-of-life trajectories identified three exploratory patterns, including a persistent-burden group; for remission, month-one DLQI updating improved AUROC to 0.753 with calibration, while baseline DLQI alone matched/outperformed ensembles for improvement. This is a retrospective telepharmacy cohort result and shows limited incremental value of complex ML.
Technology: Ward clustering identifies DLQI trajectory groups; repeated-split machine-learning models update psoriasis-remission risk from month-one scores.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Ward clustering identifies DLQI trajectory groups; repeated-split machine-learning models update psoriasis-remission risk from month-one scores.
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2026.1961097/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.